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In this issue of Structure, Gupta and colleagues apply a combination of biophysical approaches to study
the solution properties of prototype foamy virus (PFV) integrase alone and in complex with viral DNA ends
(intasome). The results complement and extend previous structural studies of PFV intasomes by X-ray
crystallography and highlight the synergy of solution and crystallographic approaches to the study of nucle-
oprotein complexes.Integration of retroviral DNA into cellular
DNA is an essential step in the replica-
tion cycle of retroviruses. The virally en-
coded integrase protein is the key enzyme
that carries out the DNA cutting and
joining steps. Viral DNA is synthesized
by reverse transcription in the cytoplasm
and remains associated with viral and
cellular proteins as a large nucleoprotein
complex called the preintegration com-
plex (PIC). After transport from the cyto-
plasm to nucleus, integrase within the
PIC catalyzes insertion of the viral DNA
into chromosomal DNA. Functional
studies of PICs show that integrase is
tightly bound to the viral DNA ends, but
the low abundance of PICs in extracts of
infected cells prevents direct analysis of
the structure and organization of the
complex. Purified retroviral integrases
catalyze integration in vitro in the pres-
ence of a divalent metal ion. These reac-
tion systems have proved to be invaluable
for studying the biochemical mechanism.
Integration occurs by a one step direct
transesterification reaction in which the30 ends of the viral DNA attack a pair of
phosphodiester bonds at the sites of inte-
gration into the target DNA (Engelman
et al., 1991). The first stable nucleoprotein
complex on the integration reaction
pathway is the stable synaptic complex
(SSC), comprising a pair of viral DNA
ends synapsed by a tetramer of integrase
(Li et al., 2006). The integration product
remains tightly associated with the
integrase tetramer in another stable
complex called the strand transfer com-
plex (STC). Collectively, these complexes
are referred to as intasomes.
Structural studies of retroviral inte-
grases have progressed at a painfully
slow pace. The structures of the indi-
vidual domains of several integrases
were determined by the mid 1990s, and
two domain structures were later deter-
mined (Chiu and Davies, 2004). Apart
from the conserved catalytic core domain
dimer interface, the relative positions of
the domains differed among the struc-
tures, highlighting the flexibility of the
domain linkers in the absence of DNA.The major obstacle to structural studies
is the propensity of integrases to aggre-
gate, especially in the presence of viral
DNA substrate and under conditions
where the enzyme is active. The first
intasome structures were not deter-
mined until 2010 when Cherepanov and
colleagues solved the structure of
prototype foamy virus (PFV) SSC and
STC intasomes (Hare et al., 2010; Maert-
ens et al., 2010). This major advance was
facilitatedby the vastly superior properties
of the PFV enzyme compared with the
more extensively studies HIV-1 and avian
counterparts. Unlike the HIV-1 and avian
integrases, PFV integrase efficiently forms
homogeneous SSC on short oligonucleo-
tides with the sequence of the viral DNA
ends and is highly active in vitro. The
PFV intasomes are currently the only re-
troviral intasomes for which crystal struc-
tures have been determined and are
therefore the best template for modeling
HIV-1 intasomes. High-resolution struc-
tures of the HIV-1 intasomes are required
because current inhibitors of integrase
Figure 1. Cartoon Representation of the PFV SSC
Structure
The integrase monomers in the intasome are distinguished
by their colors. The catalytic core domain (CCD), N-terminal
domain (NTD), C-terminal domain (CTD), and N-terminal
extension domain (NED) are distinguished by shape. The pair
of viral DNA ends is represented as helices. All the contacts
between integrase and viral DNA are with the inner subunits.
The CTD, NTD, and NED of the outer subunits are disordered.
This figure is reproduced from Craigie, 2012.
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Previewsbind to the intasome but have only
very low affinity for the protein in
the absence of DNA.
The PFV intasome structures are a
sensational step forward in the field
but leave some questions unan-
swered. One limitation is that all the
current PFV intasome structures
(Hare et al., 2010, 2012; Maertens
et al., 2010; Yin et al., 2012) were
determined from crystals with the
same lattice contacts. It is therefore
satisfying that the overall structure
determined crystallographically is
consistent with the solution studies
presented in the new paper (Gupta
et al., 2012) in this issue of Structure.
The PFV intasome is a dimer of
dimers, and all the contacts with
viral DNA are with the inner
monomers (Figure 1). Only the cata-
lytic domains of the outer monomers
are seen and the other domains of
the outer monomers are disordered.
Are these other domains required for
function? Although they are clearly
not rigidly constrained within the in-
tasome, solution studies can poten-
tially reveal information on their
dynamics that can suggest testable
models. How does the organization
of the domains of PFV integrase in
the absence of DNA relate to their
organization in the intasome? These
are the main questions Gupta et al.
(2012) address by a combination of
small angle X-ray and neutron scat-tering (SAXS/SANS), analytical centrifu-
gation, and light scattering.
Gupta et al. (2012) confirm that PFV
integrase is a homogeneous monomer in
solution in the absence of DNA. As might
be expected from the major role of
protein-DNA contacts in organizing the
intasome as revealed by the crystal struc-
ture, the spatial relationship between the
integrase domains in the absence of DNA
differs from that in the intasome. The data
are consistent with an ensemble of com-
pact structures, but not the extended
arrangement of the N-terminal and C-ter-
minal domains relative to the catalytic
domain that is seen in the intasome crystal
structure. Assembly of the intasome is
therefore accompanied by a major rear-
rangement of the integrase domains.
Although there are currently no structuresof HIV-1 intasomes, it is known that inte-
grase within the HIV-1 intasome is tetra-
meric, and it is often assumed that the
tetramer within the intasome is the same
as the tetramerof free integrase in solution.
This is unlikely to be the case, given the
role of protein-DNA contacts in holding
the PFV intasome together, and the new
studies clearly show that for PFV the
domain organization in the absence of
DNA and in the intasome are different.
The PFV intasome crystal structures fit
within the envelope derived from the
SANS and SAXS data, but additional
protein components, likely the missing
domains of the inactive outer subunits,
form lobes at the ends of the elongated
envelope. In addition, the DNA exits from
the intasome at a shallower angle relative
to the long axis of the ellipsoid than inStructure 20, November 7, 2012 ª2012the intasome crystal structures. In
the crystal structure, the DNA plays
a major role in forming the lattice
contacts, and the lattice would
prevent the missing domains from
occupying the positions inferred
from the SANS/SAXS data. The
function of the outer domains that
aremissing from the intasomecrystal
structures remains to bedetermined.
Guptaet al. (2012) speculate that that
these missing domains might be
involved in stabilizing the intasome
either before or after target capture
or perhaps be involved in interaction
with cellular factors. The inferred
location is far away from target DNA,
and the alternative function of a role
in target DNA binding would not
seem to be possible without major
rearrangements. Structures of other
retroviral intasomes will likely be
required to definitively answer the
questions that have been raised by
the recent success of structural
studies of PFV intasomes.
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